8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door
|
|
- Derrick Harrison
- 5 years ago
- Views:
Transcription
1 California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives Gloria Miele, PhD, Learning Collaborative Coordinator, Hub and Spoke MAT Expansion Project Richard Rawson, PhD, Professor Emeritus, UCLA UCLA Integrated Substance Abuse Programs DHCS Statewide Conference, Garden Grove, CA August 21, 2018 Agenda Update on California s Hub and Spoke MAT expansion project The realities of providing MAT in community health and specialty treatment centers Provider and consumer perspectives on medication-assisted treatment Karl Kaplan, MD, Tarzana Treatment Center Gilmore Chung, MD, Venice Family Clinic and UCLA Health Priscilla Romero, Consumer Questions and discussion No Wrong Door 1
2 CA Hub & Spoke System Based on the Vermont Hub & Spoke Model Harnesses the strengths of specialty methadone NTPs and skills of physicians and advanced practice clinicians who prescribe buprenorphine in office-based settings. NTPs are the only entities that are allowed by federal law to provide methadone treatment for an OUD. Hubs NTPs act as Hubs, and serve as the regional consultants and subject matter experts on opioid dependence and treatment Provide care to clinically complex buprenorphine patients Manage buprenorphine inductions Support Spokes that need clinical or programmatic advice Spokes Spokes may be (1) a federally waivered prescriber, or (2) one or more federally waivered prescribers and a MAT team. Provide ongoing care for patients with milder SUD (managing induction and maintenance) and for stable patients on transfer from a Hub Monitor adherence to treatment Coordinate access to recovery supports Provide counseling 2
3 (typically a nurse) 8/16/2018 Required Services Professional medical, social work, & mental health services, onsite or by referral Access to FDA approved MAT for an OUD Access to subject matter expertise on opioid dependence and treatment for Spokes HIV and HCV testing and referral to services Case management Counseling Naloxone and training Local access to maternal addiction treatment Recovery and/or peer support services Use of the OBOT Stability Index and the Treatment Need Questionnaire tool Hub and Spoke MAT Team Panel Manager/Nurse Prescription management Call back procedure, counting films, calling pharmacies Management of drug testing Coordination of medical services with buprenorphine prescriber Help the physician educate and manage the panel of patients Behavioral Health Provider Brief Counseling or referral to more intensive services Group counseling Some clinical case management Intake of stable patients from Hub to Spoke Referrals to Hub for unstable patients Coaching to prescribers in managing patients clinical stability Hub and Spoke Interaction 3
4 California s Opioid Epidemic 2016 vs Availability of MAT Overdose Death Rates Data source: CDPH Vital Statistics Multiple Cause of Death Files via the California Opioid Overdose Surveillance Dashboard 4
5 Hub and Spoke Network Growth Aug 2017 Jun 2018 Statewide New H&S Patients Per Month by Medication (Preliminary)* Aug Sept Oct Nov Dec Jan Feb Mar Methadone Buprenorphine XR-NTX *Preliminary data: based 12 of 19 systems completing all required monthly reports Hub and Spoke Provider Survey Results Survey Respondents (n=149) 18% 34% 48% UCLA conducted surveys of all 212 known Hub and Spoke providers from May June surveys were completed in total: 72 Waivered Providers (MD, NP, PA, etc.) 51 MAT Team (RN, Counselors, Etc.) 27 Hub Leadership (directors, coordinators, administrators) 5
6 18% Survey Results: Knowledge and Attitudes MAT Team members agree/strongly agree that Methadone is just substituting one addiction for another. 16% I feel equally comfortable working with patients with OUD as I do working with other patient groups. Waivered prescribers disagree/strongly disagree that Icon made by Freepik from Survey Results: Primary Care Settings Waivered prescribers 35% agree/strongly agree that Treating patients with OUD in primary care settings could negatively impact the workload of clinic staff. 19% Waivered prescribers agree/strongly agree that Treating patients with OUD in primary care settings might drive away other primary care patients. Icons made by Kiranshastry Survey Results: Diversion and Tapering 1/4 59% Agree or Strongly Agree that patients who divert buprenorphine or other opioids should be discharged from care immediately. Among these respondents, only 59% agreed that they felt confident in their abilities to detect diversion behaviors Waivered providers who had never prescribed buprenorphine were more likely than those who had that to agree that all patients should be tapered off of buprenorphine as soon as possible (p <.05) 6
7 Results from Vermont Hub and Spoke The H&S Evaluation: Spoke Participant Themes Participation in MAT had profound benefits in many domains of patients lives. The spoke environment was a powerful positive influence on participants self-esteem and attitude toward treatment. Participants reported their relationships with their doctor was a very powerful and positive aspect of treatment. Receiving MAT at spokes was very similar to receiving routine medical care. Buprenorphine was viewed as very positive and important. Participants felt minimal stigma at spokes, but they reported they experienced stigma when they accessed medical services in the larger healthcare system. The H&S Evaluation: Conclusions Participation in MAT was associated with: a very large reduction in opioid use a substantial reduction in other drug/alcohol use, except cannabis. a substantial reduction in drug injection a large reduction in ED visits and overdoses. a slight increase in education/training activities, but not in days of employment. a 90% reduction in both days of illegal activity and contacts with police. a substantial decrease in family conflict and improvement in measures of mood. 7
8 The H&S Evaluation: Conclusions Participants treated in the hubs with methadone and those treated in the spokes with buprenorphine showed similar and positive responses to MAT in virtually all measurement domains. Participants in both settings viewed MAT positively and as very helpful to them. Spoke patients view their relationship with their MD as very valuable. Spoke patients rated their care as helping them to a greater degree in three of the four assessed domains. Family members/significant others (FM/SOs) were uniformly grateful and appreciative of the availability of treatment. FM/SOs expressed interest in being involved in the treatment but felt that such involvement was actively discouraged. They also identified other service deficiencies The H&S Evaluations: Closing Thoughts The Vermont Hub-and-Spoke System of Care for Opioid Use Disorders is an innovative and constructive public health response to the opioid epidemic of the 21 st century in the United States. The H & S system has markedly expanded access to MAT and improved participants lives. The services provided within this model have saved many lives and have allowed many Vermonters to discontinue opioid use and improve their lives. Patient perspectives from Vermont People with OUD are very positive about treatment in primary care settings They experience little stigma and feel they are treated like all the other patients They are treated with respect and receive individualized care 8
9 Community Health Center Involvement Kaiser Family Foundation Collected data on community health centers (CHCs)in conjunction with the Affordable Care Act Used data from questions on how centers are approaching the opioid crisis Online surveys mailed to all CEOs of federally funded community health centers in all 50 states and DC from early January to late February 2018 N= % (489) survey responses from 49 states and DC Most health centers have seen an increase in patients with OUD 9
10 Nearly half of health centers provide MAT CHCs are increasing number of waivered prescribers CHCs report capacity challenges 10
11 Next Steps Ensure More Prescribers are Available Make training and support more available Expert facilitator project Independent consultant provides onsite and tele/video conferencing with Spoke providers and teams CSAM Medical Education Research Fellowship Provide additional mentorship and education to prescribers Provide the Least Restrictive Level of Care Methadone buprenorphine naltrexone One size does not fit all Convenience for patients integration back into the community Work School Family Long-term costs for society 11
12 Pain and SUD Science and practice of treating pain in the context of opioid use disorder Series of conferences for primary care providers Clinical presentations and case discussion Oakland (9/18), San Bernardino (9/26), Fresno/Clovis (10/10) Combat Stigma Public education campaigns Upcoming webinar on Stigma and OUD, Sept. 6, 10am Hearing from people involved in different aspects of the treatment system Avoid stigmatizing language (addict, relapse, dirty vs. clean, etc.) Panelists Karl Kaplan, MD, Tarzana Treatment Center Gilmore Chung, MD, Venice Family Clinic and UCLA Health Priscilla Romero, Consumer 12
13 Questions and Discussion For more information, contact Gloria Miele, Ph.D Join our listserve! 13
Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationRI Centers of Excellence for the
RI Centers of Excellence for the Treatment of Opioid Use Disorder COE CODAC Behavioral Healthcare Linda Hurley President/CEO 9-18-17 for the Warren Alpert Medical School of Brown University RI s Strategic
More informationCalifornia Hub and Spoke System Evaluation
California Hub and Spoke System Evaluation Darren Urada, Ph.D. and Howard Padwa, Ph.D. UCLA Integrated Substance Abuse Programs August 23, 2016 Substance Use Disordeers Statewide Conference Pomona, CA
More informationThe Care Alliance for Opioid Dependence
The Care Alliance for Opioid Dependence The Vermont Hub and Spoke Model John Brooklyn, MD Clinical Assistant Professor of Family Practice and Psychiatry University of Vermont College of Medicine Medical
More informationHub and Spoke Model:
Hub and Spoke Model: Increasing MAT Treatment Access in Los Angeles County Desirée A. Crèvecoeur-MacPhail, PhD UCLA Integrated Substance Abuse Program Los Angeles CA 1 History In L.A. County, some medications
More informationCalifornia s MAT Expansion Hub and Spoke System: Introduction to the Learning Collaborative
California s MAT Expansion Hub and Spoke System: Introduction to the Learning Collaborative Gloria Miele, Ph.D., Tom Freese, Ph.D., UCLA ISAP Mark McGovern, Ph.D., Stanford University September 25 and
More informationVermont Hub and Spoke Model Treatment Need Questionnaire
Vermont Hub and Spoke Model Treatment Need Questionnaire Friday, June 30, 2017 John Brooklyn, MD Assistant Professor of Family Medicine and Psychiatry University of Vermont Burlington, Vermont Webinar
More informationStatus of Opioid Treatment Efforts
Status of Opioid Treatment Efforts Health Reform Oversight Committee October 25, 2016 Harry Chen, MD, Commissioner The National Safety Council Categorized Vermont as One of Four States Making Progress
More informationChanging Course: statewide efforts to combat the opioid epidemic in California
Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries
More informationHospitals Role in Addressing the Opioid Crisis
Hospitals Role in Addressing the Opioid Crisis Webinar 5: Buprenorphine in the Emergency Department November 14, 2017 Agenda Hospital Based Buprenorphine Initiatives Yngvild Olsen, M.D., Medical Consultant,
More informationAddressing the Opioid Crisis Policy Recommendations
Addressing the Opioid Crisis Policy Recommendations The Pew Charitable Trusts Pew is an independent nonprofit, nonpartisan research and policy organization. Tools: Research Partnerships Technical assistance
More informationDriving Under the Influence (DUI) Medication Assisted Treatment (MAT) Integration/Outreach Pilot Project. Stakeholder Informing Webinar February 2019
Driving Under the Influence (DUI) Medication Assisted Treatment (MAT) Integration/Outreach Pilot Project Stakeholder Informing Webinar February 2019 1 Webinar Guidelines Controls at the bottom of the screen
More informationAn Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder
An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder CONTENTS I. Need for an Alternative Payment Model for Opioid Use Disorder and Addiction... 2 A. Improving Services
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationClosing the Loop in Treating Opioid Addiction:
Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:
More informationOUD & MAR: Caring for Our Communities
OUD & MAR: Caring for Our Communities Speaker: Elisabeth Fowlie Mock, MD, MPH Video Resources Diversion Alert/recoveryinme video https://www.youtube.com/watch?v=q1lsmwwwm40 CDC Videos RX Awareness Campaign
More informationThe MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School
The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School Disclosures Neither I nor my spouse/partner has a relevant
More informationState Opioid Response (SOR) Grant
State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics
More informationCalifornia s Hub and Spoke System Learning Collaborative 3
California s Hub and Spoke System Learning Collaborative 3 Talking to Patients about MAT Gloria Miele, Ph.D., Learning Collaborative Coordinator UCLA Integrated Substance Abuse Programs (ISAP) Mark McGovern,
More informationManagement of Opioid Use Disorder in Primary Care
1 Northwest ATTC presents Management of Opioid Use Disorder in Primary Care Joseph O. Merrill, MD, MPH University of Washington Associate Professor of Medicine 4/26/2018 Today s Presenter 2 Joseph Merrill,
More informationOffice Based Addiction Treatment (OBAT) at Lowell Community Health Center. Shaun Farraher, MD Melanie Priestly, Director May 2018
Office Based Addiction Treatment (OBAT) at Lowell Community Health Center Shaun Farraher, MD Melanie Priestly, Director May 2018 Lowell CHC OBAT Program Snapshot Number of current active patients: 225
More informationThe Opioid Crisis: What Can Physicians Do About It?
The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures
More informationSTATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce
STATEMENT of the American Medical Association for the Record House Committee on Energy and Commerce RE: Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives October
More informationDHCS Tribal MAT Project
DHCS Tribal MAT Project Melissa Eidman & Valentine Antony California Consortium for Urban Indian Health August 2018 CaliforniaConsortiumforUrbanIndianHealth CCUIH StrengtheningTheOrganizationsThatStrengthenOurCommunities
More informationSC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC
SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a
More informationCHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers
CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers DISCLOSURES None. OVERVIEW Basic description- context and system overview
More informationWorking with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
More informationInterdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings
Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures
More informationProviding Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics
More informationSANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery
Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018
More informationImproving the Quality of Addiction Treatment
Improving the Quality of Addiction Treatment Expanding Access to Medication-Assisted Treatment in Residential Addiction Treatment Programs Webinar sponsored by RTI International January 18, 2018 RTI International
More informationSubstance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates
Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral
More informationBUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES
BUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES BACKGROUND In September 2012, the Division of Medicaid (DOM) implemented criteria through electronic prior authorization (PA)
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationMedication Assisted Treatment
Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,
More informationVIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC
1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug
More informationMGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT
Bridging the Gap: Bridging the Gaps to addiction treatment through comprehensive collaborative practice among Advanced Practice Nurses in a large urban Medical Center Dawn Williamson, RN, DNP, PMHCNS-BC,
More informationCare in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities
Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More informationBuprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH
2 Buprenorphine Order Set and Rapid Access Referral 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationMedication Assisted Treatment (MAT) Program. MCPA Presentation Monday, July 24 th, 2017
Medication Assisted Treatment (MAT) Program MCPA Presentation Monday, July 24 th, 2017 MyCare Health Center Presenter: Karen Wood, RD CEO Objectives Explain MyCare s MAT program History Statistics Contracts
More informationMedication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs
Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs
More informationEXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS
EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we
More informationOpioid Overview Admiral Brett P. Giroir, M.D.
A S S I S TA N T S E C R E TA RY F O R H E A LT H Opioid Overview Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioid Policy @HHS_ASH August 20, 2018 SUBSTANCE ABUSE
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationSUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS
SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS Presented by: John M. Connolly, Ph.D. Acting Deputy Director Los Angeles County Health Agency Department of Public Health Substance Abuse Prevention
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationNIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse
NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:
More informationDPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH
DPH programs related to opioid use disorder Judith Martin, MD Medical Director of Substance Use Services SFDPH Opioid safety, SF timeline Opioid agonist treatment: methadone Seven clinics contract with
More informationTouchpoints Prior to Opioid Overdose Death
Touchpoints Prior to Opioid Overdose Death 7th Annual BU-CTSI Translational Science Symposium May 3, 2018 Marc Larochelle, MD, MPH Assistant Professor of Medicine Boston Medical Center and Boston University
More informationMission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of
Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of amphetamines and opioids, both prescription and illicit, among
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationADDING EVEN MORE SUBSTANCE TO MANAGED CARE
HEALTH WEALTH CAREER ADDING EVEN MORE SUBSTANCE TO MANAGED CARE OPTIMIZING MEDICAID TO RESPOND TO SUBSTANCE USE DISORDERS NATIONAL ACADEMY FOR STATE HEALTH POLICY 30TH ANNUAL STATE HEALTH POLICY CONFERENCE
More informationTrends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville
Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted
More informationManagement Options for Opioid Dependence:
Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice
More informationNCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project
NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Introduction The North Central Accountable Community of Health (NCACH) is accepting applications from partners
More informationTreating Emergency Room Opioid Withdrawal with Buprenorphine
Treating Emergency Room Opioid Withdrawal with Buprenorphine Monday, February 11th (3:45pm 4:30pm) Room W314B Christine Bucago, Advanced Practice Clinical Leader (Nursing), CAMH Jane Paterson, Director,
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationThe Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016
The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of
More informationIntroduction to the Massachusetts Consultation Service for the Treatment of Addiction and Pain. March 12 and March 13, 2019
Introduction to the Massachusetts Consultation Service for the Treatment of Addiction and Pain March 12 and March 13, 2019 Providers Needs Related to Treating Patients with SUD and Chronic Pain Provider
More informationCity of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)
City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS) Vancouver Vancouver Fire Rescue Services Opioid Crisis Background Crisis Overview April
More informationImproving Opioid Agonist Therapies with System Change
Improving Opioid Agonist Therapies with System Change DENNIS MCCARTY OHSU- PSU SCHOOL OF PUBLIC HEALTH OREGON HEALTH & SCIENCE UNIVERSITY PORTLAND, OR 97239 BOOST LAUNCH VANCOUVER, BC SEPTEMBER 15, 2017
More informationWhat would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017
What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD kpfeifer@chcf.org May 5, 2017 Beth Name and picture changed What we believed then Opioids are safer than alternatives
More informationOpioid Prescribing Improvement Program
Opioid Prescribing Improvement Program Jeff Schiff, MD, MBA, Medical Director of Minnesota Health Care Programs Sarah Rinn, MPH, Opioid Prescribing Improvement Program Coordinator Agenda Opioid Prescribing
More informationHospitals Role in Addressing the Opioid Crisis
Hospitals Role in Addressing the Opioid Crisis Webinar 4: Overdose Survivors Outreach Project October 18, 2017 Agenda Overdose Survivors Outreach Project (OSOP) Background Barry Page, Director of Early
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More informationOregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
More informationState Targeted Response to the Opioid Crisis. California Strategic Plan
State Targeted Response to the Opioid Crisis California Strategic Plan Prepared for the Department of Health Care Services California Health and Human Services Agency Submitted August 30, 2017 UCLA Integrated
More informationPotential Solutions to Epidemic Substance Abuse in US and Europe
Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine
More informationVeterans Health Administration Pharmacy Benefits Management Academic Detailing Services
Veterans Health Administration Pharmacy Benefits Management Academic Detailing Services Melissa Christopher, Pharm.D. National Director, Academic Detailing Services VACO PBM San Diego, California USA Academic
More informationReport to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report
Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted
More informationSTATE TARGETED RESPONSE TO THE OPIOID CRISIS (OPIOID STR)
STATE TARGETED RESPONSE TO THE OPIOID CRISIS (OPIOID STR) September 26, 2017 Kimberly A. Johnson, PhD, Director, Center for Substance Abuse Treatment, SAMHSA Donna Hillman, GPO and Opioid STR CSAT Project
More informationNew Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS
New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February
More informationMass General s Substance Use Disorder Initiative
Mass General s Substance Use Disorder Initiative Martha Kane, PhD Sarah Wakeman, MD, FASAM Clinical and Medical Directors, Mass General Hospital Substance Use Disorder Initiative None Disclosures Objectives
More informationTHA Medication Safety Summit. Wesley Geminn, PharmD, BCPP
THA Medication Safety Summit Wesley Geminn, PharmD, BCPP Current Trends: Overdose Deaths in 2017 72,000 Or 197 per day 8 per hour National Opioid Overdose Statistics https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates
More informationOPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION
OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION The Department of Human Services (DHS) is implementing 50 opioid use disorder (OUD) Health Homes or Centers of Excellence (COE)
More informationWisconsin s Opioid Crisis. Grape Vine Conference June 19th, 2018
Wisconsin s Opioid Crisis Grape Vine Conference June 19th, 2018 Federal Grants to Address Opioid Crisis Wisconsin Department of Health Services Division of Care and Treatment Services Grant Titles Medication-Assisted
More informationAetna s Initiative on the Opioid Epidemic
Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than
More informationMeth and Opioid Abuse Prevention Efforts
Meth and Opioid Abuse Prevention Efforts Prescription Drugs/Opioids in South Dakota Departments of Health and Social Services Drug Abuse in South Dakota South Dakota ranked 2 nd lowest in the nation for
More informationSafina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO
Using Leadership to Change Practice: A CPCCO s Journey towards Addressing the Opioid Epidemic Oregon Conference on Opioids, Pain and Addiction Treatment, May 19, 2018 Safina Koreishi, MD, MPH, Medical
More informationHHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder
HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder Brett Giroir, U.S. Department of Health and Human Services Join the conversation at #OUDTreatment #EndTheStigma Expanding
More informationA Rural Primary Care Clinic s Successful Response to the Opioid Epidemic. Dr. Kurt DeVine Dr. Heather Bell
A Rural Primary Care Clinic s Successful Response to the Opioid Epidemic Dr. Kurt DeVine Dr. Heather Bell A Call to Action / 3 A Call to Action The number of emergency room visits attributable to pharmaceuticals
More informationSTATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.
STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid
More informationCanada Regional Call. Monday, November 12, 2018
Canada Regional Call Monday, November 12, 2018 WebEx Quick Reference Welcome to today s session! Please use chat to All Participants for questions For technology issues only, please chat to Host WebEx
More information105 Panel: Addressing the Opioid Crisis: Pain Management, Addiction Treatment, and Recovery in the Context of APMs
105 Panel: Addressing the Opioid Crisis: Pain Management, Addiction Treatment, and Recovery in the Context of APMs Welcome Bill Hazel Former Secretary, Health and Human Resources, Commonwealth of Virginia
More informationStrategic Plan
2017-18 Strategic Plan 1 Strategic Planning Process The Summit County Opiate Task Force has made great strides in addressing the opiate crisis in the last few years. More than 100 Summit County citizens
More informationFighting Today s Opioid Epidemic
Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,
More informationCaring for ME Lunch & Learn Webinar
Caring for ME Lunch & Learn Webinar Hub and Spoke Model: Creating a Substance Use Disorder Services System of Care in Vermont Successes, Challenges and Future Opportunities Beth Tanzman, Director Blueprint
More informationThe Opioid Addiction Emergency In Virginia June 8, 2017
The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease
More informationClinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder
Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationSix Building Blocks Self-Assessment Questionnaire Workshop Version July 2017
July 2017 Background The Six Building Blocks were developed as part of a research project on Team Based Opioid Management in rural clinics. The three year research study is a collaboration between 20 rural
More informationProgress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations
Progress Report and 2018 Legislative Opportunities related to the Maine Opiate Collaborative Recommendations April 2018 A. Destigmatize substance use disorders within the law enforcement profession 1.
More informationJust Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health
Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers
More informationOverview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone
Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Alexander Y. Walley, MD, MSc Associate Professor of Medicine Director, Addiction Medicine Fellowship Boston University
More informationFOR IMMEDIATE RELEASE MARCH
FOR IMMEDIATE RELEASE MARCH 20, 2018 Contact: Jeff Washington, Deputy Executive Director, ACA, Alexandria, VA jeffw@aca.org 703-224-0103 Contact: Bob Davis, VP, Marketing, Membership & Engagement, ASAM,
More informationMedication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.
Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction
More information